|
| Press Releases |
|
 |
|
| Friday, March 24, 2023 |
|
|
医思健康与诺辉健康达成战略合作 共同推动「宫证清」在港上市 |
| 医思健康（2138.HK）与诺辉健康（6606.HK）今日举行签约仪式，双方达成独家战略合作，未来将全面整合双方的优质资源，共同推动宫证清在中国香港的注册上市、分销及市场推广，以居家早筛助力宫颈癌预防医学服务的普及，加速实现宫颈癌的有效预防。 more info >> |
|
|
醫思健康與諾輝健康達成戰略合作 共同推動「宮證清」在港上市 |
| 醫思健康（2138.HK）與諾輝健康（6606.HK）今日舉行簽約儀式，雙方達成獨家戰略合作，未來將全面整合雙方的優質資源，共同推動宮證清在中國香港的註冊上市、分銷及市場推廣，以居家早篩助力宮頸癌預防醫學服務的普及，加速實現宮頸癌的有效預防。 more info >> |
|
|
EC Healthcare Collaborates with New Horizon Health to form Strategic Partnership To Jointly Launch CerviClear in Hong Kong |
| EC Healthcare (2138.HK) and New Horizon Health (6606.HK) host ceremony today to form an exclusive strategic partnership. Both parties will consolidate the resources to empower the launching, distribution, and promotion of CerviClear in Hong Kong. more info >> |
|
| Friday, August 19, 2022 |
|
|
New Horizon Health Announced 2022 Interim Report: Revenue Up 414% YoY, Gross Margin Climbs to 82% |
New Horizon Health (6606.HK), China's leading biotechnology company for early cancer screening, announced its half-year results for the year ended June 30, 2022 today.
more info >> |
|
| Friday, March 18, 2022 |
|
|
诺辉健康发布2021年报：营收同比增长202%，毛利率攀升至72.7% |
| 中国领先的癌症早筛生物高科技公司诺辉健康（6606.HK）今日发布2021年截至12月31日的年度业绩报告。 more info >> |
|
|
諾輝健康發佈2021年報：營收同比增長202%，毛利率攀升至72.7% |
| 中國領先的癌症早篩生物高科技公司諾輝健康（6606.HK）今日發佈2021年截至12月31日的年度業績報告。 more info >> |
|
| Saturday, August 21, 2021 |
|
|
New Horizon Health Announces 2021 Interim Results: Revenue Increases 317% Year-on-year, Gross Profit Margin Climbs to 56.2% |
| New Horizon Health (6606.HK) (the "Company"), the first public listed cancer screening company in China, has today announced its financial report for the first half year ended 30 June 2021. more info >> |
|
| Friday, August 20, 2021 |
|
|
諾輝健康發佈2021年中報業績：營收同比增長317%，毛利率攀升至56.2% |
| 中國首家專注於癌症早篩的生物高科技公司諾輝健康（6606.HK）今日發佈2021年上半年截至6月30日的財務報告。 more info >> |
|
| Monday, February 8, 2021 |
|
|
基因检测行业的未来明珠获资本巨头鼎力相助 诺辉健康潜力十足 |
| 开年至今，港股市场氛围热烈，康希诺生物、荣昌生物、康方生物等生物科技公司涨势喜人。由于新冠肺炎疫情仍在世界范围扩散，促使医疗需求急剧上升，此类生物科技领域的「18A上市公司」自2020年以来愈发受到市场关注，股价表现亮眼。 more info >> |
|
|
基因檢測行業的未來明珠獲資本巨頭鼎力相助 諾輝健康潛力十足 |
| 開年至今，港股市場氛圍熱烈，康希諾生物、榮昌生物、康方生物等生物科技公司漲勢喜人。由於新冠肺炎疫情仍在世界範圍擴散，促使醫療需求急劇上升，此類生物科技領域的「18A上市公司」自2020年以來愈發受到市場關注，股價表現亮眼。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TruMerit 與 NAPNAP 攜手開發全球性小微認證，專注於兒科護理照護領域
Dec 18, 2025 07:00 HKT/SGT
|
|
|
TruMerit与NAPNAP携手开发全球儿科护理微认证
Dec 18, 2025 07:00 HKT/SGT
|
|
|
TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care
Dec 18, 2025 07:00 HKT/SGT
|
|
|
1World Online and Culinary Heritage Announce Strategic Partnership and Joint Launches in Europe
Dec 17, 2025 23:29 HKT/SGT
|
|
|
キリンと富士通、創薬DX技術を活用し、AIと実試験でシチコリンの腸脳作用メカニズムを解明
Dec 17, 2025 15:30: JST
|
|
|
マツダ、「D&I AWARD」において最上位「ベストワークプレイス」に2年連続認定
Dec 17, 2025 12:00: JST
|
|
|
Anson Resources: Update on Cooperation between Anson and POSCO Holdings for DLE Green River Demonstration Plant
Dec 17, 2025 07:00 HKT/SGT
|
|
|
AWM 以多座衝浪場館盛大開幕，為 2025 年劃下完美句點
Dec 16, 2025 23:05 HKT/SGT
|
|
|
AWM Wraps Up 2025 with Multiple Surf Venue Grand Openings
Dec 16, 2025 23:05 HKT/SGT
|
|
|
伊士曼、阿斯特捷利康、卡夫亨氏與寶潔榮獲OMP供應鏈大獎
Dec 16, 2025 22:00 HKT/SGT
|
|
|
伊士曼、阿斯利康、卡夫亨氏和宝洁荣获OMP供应链大奖
Dec 16, 2025 22:00 HKT/SGT
|
|
|
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards
Dec 16, 2025 22:00 HKT/SGT
|
|
|
Doubleview Gold Corp Extends Mineralization East of 2024 Conceptual Pit and Identifies Deeper Porphyry Indicators at Hat Project by Drilling 992m of 0.29% CuEq in Hole H101
Dec 16, 2025 20:29 HKT/SGT
|
|
|
美國馬球協會棕櫚灘馬拉松於佛羅里達州西棕櫚灘創下破紀錄的週末盛事
Dec 16, 2025 20:00 HKT/SGT
|
|
|
美国马球协会棕榈滩马拉松赛在佛罗里达州西棕榈滩迎来破纪录周末
Dec 16, 2025 20:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
